129 related articles for article (PubMed ID: 32055553)
1. Effect of plasma membrane monoamine transporter genetic variants on pharmacokinetics of metformin in humans.
Moon SJ; Oh J; Lee SH; Choi Y; Yu KS; Chung JY
Transl Clin Pharmacol; 2018 Jun; 26(2):79-85. PubMed ID: 32055553
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic variation and metformin response.
Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
[TBL] [Abstract][Full Text] [Related]
3. Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by
Dawed AY; Zhou K; van Leeuwen N; Mahajan A; Robertson N; Koivula R; Elders PJM; Rauh SP; Jones AG; Holl RW; Stingl JC; Franks PW; McCarthy MI; 't Hart LM; Pearson ER;
Diabetes Care; 2019 Jun; 42(6):1027-1033. PubMed ID: 30885951
[TBL] [Abstract][Full Text] [Related]
4.
Liu Z; Jia X; Wu P; Wu B; Pan Y; Zhong S; Xiao L; Song Y; Hu J; Zhou K
Pharmacogenomics; 2023 Jul; 24(10):551-560. PubMed ID: 37458617
[No Abstract] [Full Text] [Related]
5. Clinical pharmacokinetics of metformin.
Graham GG; Punt J; Arora M; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup LC; Kirkpatrick CM; Ray JE; Timmins P; Williams KM
Clin Pharmacokinet; 2011 Feb; 50(2):81-98. PubMed ID: 21241070
[TBL] [Abstract][Full Text] [Related]
6. A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators.
Yang Y; Zhang Z; Li P; Kong W; Liu X; Liu L
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34064886
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.
Duong JK; Kumar SS; Kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO
Clin Pharmacokinet; 2013 May; 52(5):373-84. PubMed ID: 23475568
[TBL] [Abstract][Full Text] [Related]
8. The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment.
Cho SK; Chung JY
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):253-62. PubMed ID: 26784938
[TBL] [Abstract][Full Text] [Related]
9. Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine.
Zhou M; Xia L; Wang J
Drug Metab Dispos; 2007 Oct; 35(10):1956-62. PubMed ID: 17600084
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Intestinal Permeability and Plasma Concentration of Metformin in Rats by the Repeated Administration of Red Ginseng Extract.
Jin S; Lee S; Jeon JH; Kim H; Choi MK; Song IS
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 31003498
[TBL] [Abstract][Full Text] [Related]
11. Mapping of biguanide transporters in human fat cells and their impact on lipolysis.
Arner P; Kulyté A; Batchelor K; Laurencikiene J; Livingston J; Rydén M
Diabetes Obes Metab; 2018 Oct; 20(10):2416-2425. PubMed ID: 29862627
[TBL] [Abstract][Full Text] [Related]
12. Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics.
Wagner DJ; Hu T; Wang J
Pharmacol Res; 2016 Sep; 111():237-246. PubMed ID: 27317943
[TBL] [Abstract][Full Text] [Related]
13. A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin.
Christensen MM; Pedersen RS; Stage TB; Brasch-Andersen C; Nielsen F; Damkier P; Beck-Nielsen H; Brøsen K
Pharmacogenet Genomics; 2013 Oct; 23(10):526-34. PubMed ID: 23873119
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes.
Song IS; Shin HJ; Shin JG
Xenobiotica; 2008 Sep; 38(9):1252-62. PubMed ID: 18728938
[TBL] [Abstract][Full Text] [Related]
15. Goldenseal-Mediated Inhibition of Intestinal Uptake Transporters Decreases Metformin Systemic Exposure in Mice.
Oyanna VO; Garcia-Torres KY; Bechtold BJ; Lynch KD; Call MR; Horváth M; Manwill PK; Graf TN; Cech NB; Oberlies NH; Paine MF; Clarke JD
Drug Metab Dispos; 2023 Nov; 51(11):1483-1489. PubMed ID: 37562957
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study.
Becker ML; Visser LE; van Schaik RH; Hofman A; Uitterlinden AG; Stricker BH
Diabetes; 2009 Mar; 58(3):745-9. PubMed ID: 19228809
[TBL] [Abstract][Full Text] [Related]
17. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
[TBL] [Abstract][Full Text] [Related]
18. Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.
Han TK; Proctor WR; Costales CL; Cai H; Everett RS; Thakker DR
J Pharmacol Exp Ther; 2015 Mar; 352(3):519-28. PubMed ID: 25563903
[TBL] [Abstract][Full Text] [Related]
19. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
[TBL] [Abstract][Full Text] [Related]
20. Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors.
Duan H; Hu T; Foti RS; Pan Y; Swaan PW; Wang J
Drug Metab Dispos; 2015 Nov; 43(11):1773-80. PubMed ID: 26285765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
